SBIR/STTR Research Award

Integration of Wolbachia-based Incompatible Insect Technique (IIT) and Auto-Dissemination Augmented by Males (ADAM) for mosquito vector control

Award identifier 9275dadcc1466d4569f2baedcb4be718e4c7c0227daf67b490e9a5b8775215d8Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$193,500

Program and phase

SBIR · Phase I

Award year

2020

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
MosquitoMate, Inc
Proposal award date
2020-06-15
Contract end date
2021-05-31
UEI
F873ZJEX7615
Solicitation number
PA19-272
Topic code
R

Research abstract

Abstract In the absence of effective, approved vaccines or therapeutic measures against dengue, Zika and other mosquito borne pathogens, public health efforts must focus on the control of mosquito vectors that are required for transmission. Unfortunately, effective control measures are not available against invasive mosquito species like Aedes aegypti and Aedes albopictus, due in part to problems resulting from their cryptic behaviour. Specifically, Aedes mosquitoes breed in hidden/inaccessible sites that are sheltered from existing control methods, e.g., truck and aerial spraying. Autocidal technologies use the insect itself as a self-delivering control tool. As an example, the Sterile Insect Technique (SIT) has been used successfully against multiple agricultural pests, including large scale elimination from the North American continent (e.g., Screwworm; Cochliomyia hominivorax). However, despite years of effort, SIT has not proven effective against mosquitoes. Through previous SBIR-funded research, MosquitoMate has developed two autocidal methods against Ae. aegypti and Ae. albopictus mosquitoes, including: 1) Incompatible Insect Technique (IIT) that uses a naturally occurring bacterium (Wolbachia) to sterilize populations, and 2) Auto-Dissemination Augmented by Males (ADAM) that uses males as vehicles to spread a potent insecticide. To date, the USA Environmental Protection Agency (EPA) has instructed MosquitoMate to keep the IIT and ADAM approaches separate. In the work proposed here, MosquitoMate will develop data that the EPA can consider for the integration of the two approaches. If awarded, the resulting research will examine parameters critical to the EPA’s efficacy and risk assessments, including potential: 1) PPF effects on Wolbachia-induced sterility, 2) PPF effects on male mosquito performance (e.g., ‘boosting’ of male competitiveness), and 3) PPF effects on adult female mosquito fecundity and fitness. The resulting data will be communicated to the EPA, including a pre-registration meeting to identify requirements leading to FIFRA Section 3 EPA pesticide registration for the combined IIT/ADAM approach. Market potential exists at the local, corporate, government and area wide control levels for the control of invasive, medically important mosquito species. MosquitoMate has an exclusive license for the patented Wolbachia technology and additional patents on the ADAM technology.Narrative Vector control remains the only means to combat many mosquito borne diseases, including those caused by Zika, dengue, chikungunya viruses and other pathogens. A critical existing gap in vector control is the inability to affect the immature proportion of the mosquito population that remains hidden/protected within cryptic breeding sites and inaccessible to conventional control tools. The proposed work will test the feasibility of integrating the Incompatible Insect Technique and an approach in which male mosquitoes disseminate a potent larvicide. Key advantages of integration include improved performance, risk mitigation and reduced cost. The data resulting from the proposed work can be provided to the EPA in support of FIFRA Section 3 EPA pesticide registration.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Research funding history

5 SBIR/STTR records share this UEI (2012–2020). Reported award amounts total $4,141,510. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.